Escalade Inc. (ESCA) Jumps 9.41% on January 13

Equities Staff |

Escalade Inc. (ESCA) was among the biggest gainers on the Russell 2000 for Wednesday January 13 as the stock popped 9.41% to $12.91, representing a gain of $1.11 per share. Some 34,116 shares traded hands on 341 trades, compared with an average daily volume of 20,752 shares out of a total float of 14.13 million. The stock opened at $12.15 and traded with an intraday range of $13.39 to $12.15.

After today's gains, Escalade Inc. reached a market cap of $182.42 million. Escalade Inc. has had a trading range between $20.00 and $10.70 over the last year, and it had a 50-day SMA of $12.53 and a 200-day SMA of $16.32.

The stock has a P/E Ratio of 13.

Escalade Inc manufactures, & distributes sporting goods brands in basketball goals, archery, indoor & outdoor game recreation & fitness products through retailers, specialty dealers, key on-line retailers, traditional department stores & mass merchants.

Escalade Inc. is based out of Evansville, IN and has some 466 employees. Its CEO is David L. Fetherman.

For a complete fundamental analysis analysis of Escalade Inc., check out’s Stock Valuation Analysis report for ESCA. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Propanc Health Group Corp

Propanc Health Group Corp is an early stage healthcare company. It is engaged in developing new cancer treatments for patients, suffering from pancreatic and colorectal cancer.

Private Markets


Lyft matches drivers using their own personal vehicles with passengers who request rides through the smartphone app, and the passengers pay automatically through the app. When using Lyft, passengers have…


The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…